Iceland vs Zimbabwe: Access to anti-retroviral drugs, male
Iceland
89.0%
in 2024
Zimbabwe
89.0%
in 2024
Iceland rank
17th
Zimbabwe rank
17th
Access to anti-retroviral drugs, male over time
- Iceland
- Zimbabwe
How they compare
Iceland currently reports 89.0% against 89.0% in Zimbabwe, a difference of 0.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Iceland ahead.
Iceland ranks 17th and Zimbabwe ranks 17th of 141 countries.
Across the 3 decades both report, Iceland averaged higher in 2 and Zimbabwe in 1.
Head to head by decade
| Decade | Iceland | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.3% | 4.1% | 41.2% | Iceland |
| 2010s | 68.6% | 52.9% | 15.7% | Iceland |
| 2020s | 86.4% | 88.4% | 2.0% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Iceland or Zimbabwe?
- Iceland, at 89.0% against 89.0% in Zimbabwe as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Iceland and Zimbabwe?
- 0.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Zimbabwe?
- 25 years are reported by both, from 2000 to 2024.
- How do Iceland and Zimbabwe rank globally for access to anti-retroviral drugs, male?
- Iceland ranks 17th and Zimbabwe ranks 17th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.